-
Preferences Among U.S. Women for Cervical Cancer Screening with Self-Collected Specimens for Human Papillomavirus Testing. Obstet Gynecol. 2026 Mar 01; 147(3):306-312. Qin J, Martinez G, Holt HK, Gopalani SV, Trivers KF, Miller JW, Senkomago V, Sawaya GF. PMID: 41380156; PMCID: PMC12797866.
-
The impact of age at initial HPV vaccination on cervical cancer screening participation in a nationally representative cohort of women in the United States. J Med Screen. 2025 Sep; 32(3):126-132. Chirikova E, Dorismond V, Cortella AM, DeRouen MC, Sawaya GF. PMID: 39881610; PMCID: PMC12354982.
-
Cervical Cancer Screening Among Female Medicaid Beneficiaries With and Without Schizophrenia. Schizophr Bull. 2024 11 08; 50(6):1499-1507. Hwong AR, Murphy KA, Vittinghoff E, Alonso-Fraire P, Crystal S, Walkup J, Hermida R, Olfson M, Cournos F, Sawaya GF, Mangurian C. PMID: 38842724; PMCID: PMC11548919.
-
Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalence. J Natl Cancer Inst. 2024 Sep 01; 116(9):1525-1529. Das S, Wentzensen N, Sawaya GF, Egemen D, Locke A, Kinney W, Lorey T, Cheung LC. PMID: 38830048; PMCID: PMC12116295.
-
Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study. AIDS. 2024 Dec 01; 38(15):2030-2039. Zhao R, Sanstead E, Alarid-Escudero F, Huchko M, Silverberg M, Smith-McCune K, Gregorich SE, Leyden W, Kuppermann M, Sawaya GF, Kulasingam S. PMID: 39229757; PMCID: PMC11666405.
-
The impact of adjusting for hysterectomy prevalence on cervical cancer incidence rates and trends among women aged 30 years or older-United States, 2001-2019. Am J Epidemiol. 2024 Aug 05; 193(8):1097-1105. Gopalani SV, Sawaya GF, Rositch AF, Dasari S, Thompson TD, Mix JM, Saraiya M. PMID: 38583940; PMCID: PMC12053814.
-
Tubal Sterilization and Cervical Cancer Underscreening in the United States. J Womens Health (Larchmt). 2024 Jun; 33(6):729-733. Holt HK, Martinez G, Reyes MF, Saraiya M, Qin J, Sawaya GF. PMID: 38502830; PMCID: PMC11182708.
-
Variation in cervical cancer screening test utilization and results in a United States-based program. Gynecol Oncol. 2024 05; 184:96-102. Dorismond VG, Saraiya M, Gopalani SV, Soman A, Kenney K, Miller J, Sawaya GF. PMID: 38301312.
-
2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023. J Low Genit Tract Dis. 2024 Jan 01; 28(1):3-6. Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M, 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. PMID: 38117563; PMCID: PMC10755815.
-
A qualitative study of primary care clinician's approach to ending cervical cancer screening in older women in the United States. Prev Med Rep. 2023 Dec; 36:102500. Holt HK, Flores R, James JE, Waters C, Kaplan CP, Peterson CE, Sawaya GF. PMID: 38116273; PMCID: PMC10728461.
-
Avoiding Low-Value Care and Patient Financial Harm in Cervical Cancer Screening. Cancer Prev Res (Phila). 2023 07 05; 16(7):363-364. Sawaya GF, Dorismond VG. PMID: 37403658.
-
The association between YouTube use and knowledge of human papillomavirus-related cancers. PEC Innov. 2023 Dec 15; 3:100186. Dorismond VG, Boscardin WJ, Sawaya GF. PMID: 37457670; PMCID: PMC10339240.
-
Mediation of Racial and Ethnic Inequities in the Diagnosis of Advanced-Stage Cervical Cancer by Insurance Status. JAMA Netw Open. 2023 03 01; 6(3):e232985. Holt HK, Peterson CE, MacLaughlan David S, Abdelaziz A, Sawaya GF, Guadamuz JS, Calip GS. PMID: 36897588; PMCID: PMC10726717.
-
Accelerating Cervical Cancer Screening With Human Papillomavirus Genotyping. Am J Prev Med. 2023 04; 64(4):552-555. Sawaya GF, Saraiya M, Soman A, Gopalani SV, Kenney K, Miller J. PMID: 36935166; PMCID: PMC12036626.
-
Use Trends and Recent Expenditures for Cervical Cancer Screening-Associated Services in Medicare Fee-for-Service Beneficiaries Older Than 65 Years. JAMA Intern Med. 2023 01 01; 183(1):11-20. Qin J, Holt HK, Richards TB, Saraiya M, Sawaya GF. PMID: 36409511; PMCID: PMC9679959.
-
Emergency department visits and emergency-to-inpatient admissions for abnormal uterine bleeding in the USA nationwide. Emerg Med J. 2023 May; 40(5):326-332. Grubman J, Hawkins M, Whetstone S, Autry M, Lazar A, Sawaya GF, Jacoby V. PMID: 36323495.
-
Changing Preferences for a Cervical Cancer Screening Strategy: Moving Away from Annual Testing. Womens Health Rep (New Rochelle). 2022; 3(1):709-717. Schrier E, Holt HK, Kuppermann M, Sawaya GF. PMID: 36147829; PMCID: PMC9436266.
-
The Swinging Pendulum: Elective Oophorectomy at the Time of Hysterectomy. Obstet Gynecol. 2022 05 01; 139(5):721-723. Jacoby VL, Sawaya G. PMID: 35576329.
-
Computable Guidelines and Clinical Decision Support for Cervical Cancer Screening and Management to Improve Outcomes and Health Equity. J Womens Health (Larchmt). 2022 04; 31(4):462-468. Saraiya M, Colbert J, Bhat GL, Almonte R, Winters DW, Sebastian S, O'Hanlon M, Meadows G, Nosal MR, Richards TB, Michaels M, Townsend JS, Miller JW, Perkins RB, Sawaya GF, Wentzensen N, White MC, Richardson LC. PMID: 35467443; PMCID: PMC9206487.
-
Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2021 10 01; 25(4):330-331. Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M, 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. PMID: 34542089.
-
Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019. Gynecol Oncol. 2021 11; 163(2):378-384. Qin J, Shahangian S, Saraiya M, Holt H, Gagnon M, Sawaya GF. PMID: 34507826; PMCID: PMC8585712.
-
Prioritizing cervical cancer screening services during the COVID-19 pandemic: Response of an academic medical center and a public safety net hospital in California. Prev Med. 2021 10; 151:106569. Sawaya GF, Holt HK, Lamar R, Perron-Burdick M, Smith-McCune K. PMID: 34217411; PMCID: PMC8241652.
-
Effect of 2 Interventions on Cervical Cancer Screening Guideline Adherence. Am J Prev Med. 2021 05; 60(5):666-673. Moscicki AB, Chang C, Vangala S, Zhou X, Elashoff DA, Dehlendorf C, Sawaya GF, Kuppermann M, Duron Y, Wyand FL, Navarro SK, Thiel de Bocanegra H. PMID: 33632649.
-
In Reply. Obstet Gynecol. 2021 02 01; 137(2):375. LaCoursiere DY, Scott JR, Chelmow D, Young AE, Sawaya GF, DeLancey J, Learman LA. PMID: 33481512.
-
Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016-2020. J Womens Health (Larchmt). 2021 01; 30(1):5-13. Perkins RB, Guido RL, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M, Feldman S. PMID: 33464997; PMCID: PMC8020523.
-
Delayed Visits for Contraception Due to Concerns Regarding Pelvic Examination Among Women with History of Intimate Partner Violence. J Gen Intern Med. 2021 07; 36(7):1883-1889. Holt HK, Sawaya GF, El Ayadi AM, Henderson JT, Rocca CH, Westhoff CL, Harper CC. PMID: 33145695; PMCID: PMC8298732.
-
Contributions, Aspirations, and Challenges of Academic Specialist Divisions in Obstetrics and Gynecology. Obstet Gynecol. 2020 11; 136(5):981-986. LaCoursiere DY, Scott JR, Chelmow D, Young AE, Sawaya GF, Delancey J, Learman LA. PMID: 33030879.
-
Managing Minimally Abnormal Cervical Cancer Screening Test Results. JAMA. 2020 10 20; 324(15):1557-1558. Sawaya GF, Lamar R, Perkins RB. PMID: 32975557.
-
Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020 10; 24(4):426. Perkins RB, Guido RL, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya G, Wentzensen N, Schiffman M. PMID: 32732648.
-
Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers. MDM Policy Pract. 2020 Jul-Dec; 5(2):2381468320952409. Holt HK, Kulasingam S, Sanstead EC, Alarid-Escudero F, Smith-McCune K, Gregorich SE, Silverberg MJ, Huchko MJ, Kuppermann M, Sawaya GF. PMID: 32885045; PMCID: PMC7440733.
-
Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. Vaccine. 2020 06 15; 38(29):4520-4523. Silverberg MJ, Leyden WA, Lam JO, Chao CR, Gregorich SE, Huchko MJ, Kulasingam S, Kuppermann M, Smith-McCune KK, Sawaya GF. PMID: 32446836; PMCID: PMC7272293.
-
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020 04; 24(2):102-131. Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M, 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. PMID: 32243307; PMCID: PMC7147428.
-
Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States. JAMA Intern Med. 2020 02 01; 180(2):274-280. Qin J, Saraiya M, Martinez G, Sawaya GF. PMID: 31904768; PMCID: PMC7028301.
-
Social Media as a Tool to Promote Health Awareness: Results from an Online Cervical Cancer Prevention Study. J Cancer Educ. 2019 Aug; 34(4):819-822. Lyson HC, Le GM, Zhang J, Rivadeneira N, Lyles C, Radcliffe K, Pasick RJ, Sawaya G, Sarkar U, Centola D. PMID: 29948924; PMCID: PMC6289895.
-
Effect of cost exposure on medical students' preferred mammography screening strategies: A randomized comparison. Med Teach. 2019 11; 41(11):1293-1297. Nguyen C, Sawaya GF, Hoffman A. PMID: 31339438.
-
Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis. JAMA Intern Med. 2019 07 01; 179(7):867-878. Sawaya GF, Sanstead E, Alarid-Escudero F, Smith-McCune K, Gregorich SE, Silverberg MJ, Leyden W, Huchko MJ, Kuppermann M, Kulasingam S. PMID: 31081851; PMCID: PMC6515585.
-
Facts or stories? How to use social media for cervical cancer prevention: A multi-method study of the effects of sender type and content type on increased message sharing. Prev Med. 2019 09; 126:105751. Zhang J, Le G, Larochelle D, Pasick R, Sawaya GF, Sarkar U, Centola D. PMID: 31226342; PMCID: PMC6697580.
-
Receipt of Pelvic Examinations Among Women Aged 15-44 in the United States, 1988-2017. NCHS Data Brief. 2019 Jun; (339):1-8. Martinez GM, Qin J, Saraiya M, Sawaya GF. PMID: 31442190.
-
Perceptions of cervical cancer prevention on Twitter uncovered by different sampling strategies. PLoS One. 2019; 14(2):e0211931. Le GM, Radcliffe K, Lyles C, Lyson HC, Wallace B, Sawaya G, Pasick R, Centola D, Sarkar U. PMID: 30742683; PMCID: PMC6370210.
-
Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause. 2018 11; 25(11):1286-1290. Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D. PMID: 30358724.
-
Cervical Cancer Screening-Moving From the Value of Evidence to the Evidence of Value. JAMA Intern Med. 2018 10 01; 178(10):1293-1295. Sawaya GF. PMID: 30140917; PMCID: PMC6656357.
-
Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study. Lancet Child Adolesc Health. 2018 10; 2(10):707-714. Silverberg MJ, Leyden WA, Lam JO, Gregorich SE, Huchko MJ, Kulasingam S, Kuppermann M, Smith-McCune KK, Sawaya GF. PMID: 30236379; PMCID: PMC6152835.
-
Equal Management of Equal Risks: What Should be Used as the Standard for Cervical Cancer Prevention? J Low Genit Tract Dis. 2018 Jul; 22(3):237-241. Kinney WK, Perkins RB, Sawaya GF. PMID: 29794532; PMCID: PMC6023600.
-
Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018 02 13; 319(6):595-606. Henderson JT, Webber EM, Sawaya GF. PMID: 29450530.
-
Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia. Obstet Gynecol. 2018 01; 131(1):47-55. Silverberg MJ, Leyden WA, Chi A, Gregorich S, Huchko MJ, Kulasingam S, Kuppermann M, Seto A, Smith-McCune KK, Sawaya GF. PMID: 29215531; PMCID: PMC5740002.
-
Cervical Cancer Screening. Med Clin North Am. 2017 Jul; 101(4):743-753. Sawaya GF, Huchko MJ. PMID: 28577624; PMCID: PMC6585416.
-
Screening Pelvic Examinations: The Emperor's New Clothes, Now in 3 Sizes? JAMA Intern Med. 2017 04 01; 177(4):467-468. Sawaya GF. PMID: 28267832.
-
Women's beliefs about the purpose and value of routine pelvic examinations. Am J Obstet Gynecol. 2017 07; 217(1):86.e1-86.e6. Norrell LL, Kuppermann M, Moghadassi MN, Sawaya GF. PMID: 28040449; PMCID: PMC6420304.
-
Cervical cancer screening in women over 65. CON: Reasons for uncertainty. Gynecol Oncol. 2016 09; 142(3):383-4. Sawaya GF. PMID: 27545586; PMCID: PMC6656362.
-
Population-based screening for cancer: hope and hype. Nat Rev Clin Oncol. 2016 09; 13(9):550-65. Shieh Y, Eklund M, Sawaya GF, Black WC, Kramer BS, Esserman LJ. PMID: 27071351; PMCID: PMC6585415.
-
Cervical Cancer Screening. Obstet Gynecol. 2016 Mar; 127(3):459-467. Sawaya GF, Smith-McCune K. PMID: 26855089; PMCID: PMC6585413.
-
Obstetrician-Gynecologist Practices and Beliefs Regarding External Genitalia Inspection and Speculum Examinations in Healthy Older Asymptomatic Women. J Am Geriatr Soc. 2016 Feb; 64(2):293-8. Hsu A, Henderson JT, Harper CC, Sawaya GF. PMID: 26805728.
-
Re-envisioning the Annual Well-Woman Visit: The Task Forward. Obstet Gynecol. 2015 Oct; 126(4):695-696. Sawaya GF. PMID: 26348172; PMCID: PMC4721661.
-
Obstetrician-gynecologists' beliefs about performing less cervical cancer screening: the pendulum swings. Am J Obstet Gynecol. 2015 Nov; 213(5):744-5. Schneider A, Henderson JT, Harper CC, Hsu A, Saraiya M, Sawaya GF. PMID: 26184779; PMCID: PMC4722818.
-
Acceptable and Preferred Cervical Cancer Screening Intervals Among U.S. Women. Am J Prev Med. 2015 Dec; 49(6):e99-107. Cooper CP, Saraiya M, Sawaya GF. PMID: 26141914; PMCID: PMC4656074.
-
Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2015 Jun 16; 162(12):851-9. Sawaya GF, Kulasingam S, Denberg TD, Qaseem A, Clinical Guidelines Committee of American College of Physicians. PMID: 25928075.
-
A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women. PLoS One. 2015; 10(4):e0118568. Huchko MJ, Sneden J, Zakaras JM, Smith-McCune K, Sawaya G, Maloba M, Bukusi EA, Cohen CR. PMID: 25849627; PMCID: PMC4388564.
-
Defining competencies for education in health care value: recommendations from the University of California, San Francisco Center for Healthcare Value Training Initiative. Acad Med. 2015 Apr; 90(4):421-4. Moriates C, Dohan D, Spetz J, Sawaya GF. PMID: 25354077.
-
Identifying a "range of reasonable options" for cervical cancer screening. Obstet Gynecol. 2015 Feb; 125(2):308-310. Sawaya GF, Kuppermann M. PMID: 25569012; PMCID: PMC4720252.
-
Shared decision-making: easy to evoke, challenging to implement. JAMA Intern Med. 2015 Feb; 175(2):167-8. Kuppermann M, Sawaya GF. PMID: 25436939; PMCID: PMC4720254.
-
Women's clinical preventive services in the United States: who is doing what? JAMA Intern Med. 2014 Sep; 174(9):1512-4. Stormo AR, Saraiya M, Hing E, Henderson JT, Sawaya GF. PMID: 25003954; PMCID: PMC5833983.
-
Screening pelvic examinations: right, wrong, or rite? Ann Intern Med. 2014 Jul 01; 161(1):78-9. Sawaya GF, Jacoby V. PMID: 24979453.
-
Obstetrician-gynecologists' beliefs on the importance of pelvic examinations in assessing hormonal contraception eligibility. Contraception. 2014 Dec; 90(6):612-4. Yu JM, Henderson JT, Harper CC, Sawaya GF. PMID: 25108582.
-
Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya. Int J Cancer. 2015 Jan 15; 136(2):392-8. Huchko MJ, Sneden J, Sawaya G, Smith-McCune K, Maloba M, Abdulrahim N, Bukusi EA, Cohen CR. PMID: 24889387; PMCID: PMC4214890.
-
Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies. Am J Obstet Gynecol. 2014 Oct; 211(4):354.e1-6. Saraiya M, Benard VB, Greek AA, Steinau M, Patel S, Massad LS, Sawaya GF, Unger ER. PMID: 24813971; PMCID: PMC4386593.
-
U.S. clinicians' perspectives on less frequent routine gynecologic examinations. Prev Med. 2014 May; 62:49-53. Henderson JT, Yu JM, Harper CC, Sawaya GF. PMID: 24518004.
-
Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy? J Low Genit Tract Dis. 2013 Jul; 17(3):354-60. Huchko MJ, Woo V, Liegler T, Leddy A, Smith-McCune K, Sawaya GF, Bukusi EA, Cohen CR. PMID: 23486070; PMCID: PMC3690152.
-
Cervical cancer screening intervals, 2006 to 2009: moving beyond annual testing. JAMA Intern Med. 2013 May 27; 173(10):922-4. Berkowitz Z, Saraiya M, Sawaya GF. PMID: 23568334; PMCID: PMC12248000.
-
Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2013 Jul; 29(7):1000-5. Woo VG, Liegler T, Cohen CR, Sawaya GF, Smith-McCune K, Bukusi EA, Huchko MJ. PMID: 23594240; PMCID: PMC3685685.
-
Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study. BJOG. 2013 Sep; 120(10):1233-9. Huchko MJ, Woo VG, Liegler T, Leslie H, Smith-McCune K, Sawaya GF, Bukusi EA, Cohen CR. PMID: 23647852; PMCID: PMC3739995.
-
Receipt of cervical cancer screening in female veterans: impact of posttraumatic stress disorder and depression. Womens Health Issues. 2013 May-Jun; 23(3):e153-9. Weitlauf JC, Jones S, Xu X, Finney JW, Moos RH, Sawaya GF, Frayne SM. PMID: 23660429; PMCID: PMC3704317.
-
New guidelines: it's complicated. Obstet Gynecol. 2013 Apr; 121(4):703-704. Sawaya GF. PMID: 23635667.
-
NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements. 2013 Mar 06; 29(1):1-31. Vandorsten JP, Dodson WC, Espeland MA, Grobman WA, Guise JM, Mercer BM, Minkoff HL, Poindexter B, Prosser LA, Sawaya GF, Scott JR, Silver RM, Smith L, Thomas A, Tita AT. PMID: 23748438.
-
Treatment patterns for cervical carcinoma in situ in Michigan, 1998-2003. J Registry Manag. 2013; 40(2):84-92. Patel DA, Saraiya M, Copeland G, Cote ML, Datta SD, Sawaya GF. PMID: 24002133; PMCID: PMC4515306.
-
Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists. Am J Obstet Gynecol. 2013 Feb; 208(2):109.e1-7. Henderson JT, Harper CC, Gutin S, Saraiya M, Chapman J, Sawaya GF. PMID: 23159688; PMCID: PMC4350675.
-
Changes to cervical cancer prevention guidelines: effects on screening among U.S. women ages 15-29. Prev Med. 2013 Jan; 56(1):25-9. Henderson JT, Saraiya M, Martinez G, Harper CC, Sawaya GF. PMID: 23137444; PMCID: PMC4350673.
-
Evidence at the point of practice change: lung cancer screening. Arch Intern Med. 2012 Oct 08; 172(18):1415-7. Sawaya GF, Tice JA. PMID: 22965303.
-
Colorectal cancer screening: what do women from diverse ethnic groups want? J Gen Intern Med. 2013 Feb; 28(2):239-46. Walsh JM, Kim SE, Sawaya G, Kaplan CP, Wong ST, Gregorich SE, Pérez-Stable EJ. PMID: 22968796; PMCID: PMC3614137.
-
Willingness to use tamoxifen to prevent breast cancer among diverse women. Breast Cancer Res Treat. 2012 May; 133(1):357-66. Kaplan CP, Kim SE, Wong ST, Sawaya GF, Walsh JM, Pérez-Stable EJ. PMID: 22315131; PMCID: PMC4039196.
-
Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds. Patient Educ Couns. 2012 Jun; 87(3):327-35. Wong ST, Pérez-Stable EJ, Kim SE, Gregorich SE, Sawaya GF, Walsh JM, Washington AE, Kaplan CP. PMID: 22244322; PMCID: PMC3359420.
-
Pelvic examinations in asymptomatic women: tipping a sacred cow. Arch Intern Med. 2011 Dec 12; 171(22):2054-5. Sawaya GF. PMID: 22158577.
-
Investigating Potential Associations between Cervical Procedures and HIV Acquisition. ISRN Obstet Gynecol. 2011; 2011:789106. Diouf K, Sawaya GF, Shiboski S, Magure T, Makunike-Mutasa R, Darragh TM, Tuveson J, Chipato T, Palefsky JM, Moscicki AB, Chirenje M, Smith-McCune K. PMID: 22191049; PMCID: PMC3236408.
-
Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol. 2011 Nov; 118(5):1178. Sawaya GF, Jacoby V. PMID: 22015896.
-
Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. Epidemiol Rev. 2011; 33:20-35. Harris R, Sawaya GF, Moyer VA, Calonge N. PMID: 21666224.
-
Updated recommendations for breast cancer screening. Curr Opin Obstet Gynecol. 2010 Dec; 22(6):498-505. Gregory KD, Sawaya GF. PMID: 20978442.
-
Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol. 2010 Dec; 116(6):1257-1264. Henderson JT, Sawaya GF, Blum M, Stratton L, Harper CC. PMID: 21099589; PMCID: PMC3745305.
-
Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol. 2010 Nov; 116(5):1158-70. Melnikow J, Kulasingam S, Slee C, Helms LJ, Kuppermann M, Birch S, McGahan CE, Coldman A, Chan BK, Sawaya GF. PMID: 20966702.
-
The new mammographic screening guidelines: what were they thinking? Obstet Gynecol. 2010 Nov; 116(5):1216; author reply 1216-7. Sawaya GF, Gregory KD. PMID: 20966713.
-
Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions. Gynecol Oncol. 2010 Aug 01; 118(2):108-15. Kuppermann M, Melnikow J, Slee C, Tancredi DJ, Kulasingam S, Birch S, Helms LJ, Bayoumi AM, Sawaya GF. PMID: 20553960; PMCID: PMC2926130.
-
Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone". Arch Intern Med. 2010 Jun 14; 170(11):985-6. Sawaya GF. PMID: 20548012.
-
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One. 2010 Apr 08; 5(4):e10094. Smith-McCune KK, Shiboski S, Chirenje MZ, Magure T, Tuveson J, Ma Y, Da Costa M, Moscicki AB, Palefsky JM, Makunike-Mutasa R, Chipato T, van der Straten A, Sawaya GF. PMID: 20386706; PMCID: PMC2851652.
-
Cervical-cancer screening--new guidelines and the balance between benefits and harms. N Engl J Med. 2009 Dec 24; 361(26):2503-5. Sawaya GF. PMID: 19940285.
-
Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst. 2009 May 20; 101(10):721-8. Melnikow J, McGahan C, Sawaya GF, Ehlen T, Coldman A. PMID: 19436026; PMCID: PMC2684554.
-
Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis. 2009 May; 36(5):305-11. Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, Makunike-Mutasa R, Chipato T, Smith-McCune KK. PMID: 19295468.
-
MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial. Menopause. 2009 May-Jun; 16(3):458-65. Grady D, Sawaya GF, Johnson KC, Koltun W, Hess R, Vittinghoff E, Kristof M, Tagliaferri M, Cohen I, Ensrud KE. PMID: 19182698.
-
Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med. 2009 Feb 03; 150(3):199-205. Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T, U.S. Preventive Services Task Force. PMID: 19189910.
-
Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol. 2009 Apr; 200(4):422.e1-9. Chan BK, Melnikow J, Slee CA, Arellanes R, Sawaya GF. PMID: 19167697; PMCID: PMC2784953.
-
Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol. 2009 Feb; 200(2):140.e1-9. Jacoby VL, Grady D, Sawaya GF. PMID: 19019330; PMCID: PMC2770431.
-
Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial. Obstet Gynecol. 2008 11; 112(5):990-7. Sawaya GF, Chirenje MZ, Magure MT, Tuveson JL, Ma Y, Shiboski SC, Da Costa MM, Palefsky JM, Moscicki AB, Mutasa RM, Chipato T, Smith-McCune KK. PMID: 18978097.
-
Ending cervical cancer screening: attitudes and beliefs from ethnically diverse older women. Am J Obstet Gynecol. 2009 Jan; 200(1):40.e1-7. Sawaya GF, Iwaoka-Scott AY, Kim S, Wong ST, Huang AJ, Washington AE, Pérez-Stable EJ. PMID: 18976734; PMCID: PMC2643872.
-
Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women. J Gen Intern Med. 2008 Sep; 23(9):1324-9. Huang AJ, Pérez-Stable EJ, Kim SE, Wong ST, Kaplan CP, Walsh JM, Iwaoka-Scott AY, Sawaya GF. PMID: 18506546; PMCID: PMC2518007.
-
Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med. 2008 Apr 14; 168(7):728-34. Kim SE, Pérez-Stable EJ, Wong S, Gregorich S, Sawaya GF, Walsh JM, Kaplan CP. PMID: 18413555; PMCID: PMC4031902.
-
Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later. Ann Intern Med. 2008 Apr 01; 148(7):557-9. Sawaya GF. PMID: 18378951.
-
USPSTF recommendations for STI screening. Am Fam Physician. 2008 Mar 15; 77(6):819-24. Meyers D, Wolff T, Gregory K, Marion L, Moyer V, Nelson H, Petitti D, Sawaya GF, USPSTF. PMID: 18386598.
-
Evidence-based medicine versus liquid-based cytology. Obstet Gynecol. 2008 Jan; 111(1):2-3. Sawaya GF. PMID: 18165385.
-
Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med. 2007 Dec 18; 147(12):871-5. Sawaya GF, Guirguis-Blake J, LeFevre M, Harris R, Petitti D, U.S. Preventive Services Task Force. PMID: 18087058.
-
Trials that matter: liquid-based cervical cytology: disadvantages seem to outweigh advantages. Ann Intern Med. 2007 Nov 06; 147(9):668-9. Sawaya GF, Sox HC. PMID: 17975190.
-
How to read the new recommendation statement: methods update from the U.S. Preventive Services Task Force. Ann Intern Med. 2007 Jul 17; 147(2):123-7. Barton MB, Miller T, Wolff T, Petitti D, LeFevre M, Sawaya G, Yawn B, Guirguis-Blake J, Calonge N, Harris R, U.S. Preventive Services Task Force. PMID: 17576997.
-
HPV vaccination--more answers, more questions. N Engl J Med. 2007 May 10; 356(19):1991-3. Sawaya GF, Smith-McCune K. PMID: 17494933.
-
Outcomes associated with cesarean section versus vaginal breech delivery at a university hospital. J Perinatol. 2007 Mar; 27(3):141-6. Hopkins LM, Esakoff T, Noah MS, Moore DH, Sawaya GF, Laros RK. PMID: 17036031.
-
Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections. J Low Genit Tract Dis. 2006 Oct; 10(4):213-8. Smith-McCune KK, Tuveson JL, Rubin MM, Da Costa MM, Darragh TM, Shiboski SC, Van Der Pol B, Moscicki AB, Palefsky JM, Sawaya GF. PMID: 17012985.
-
Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstet Gynecol. 2006 Feb; 107(2 Pt 1):321-8. Kulasingam SL, Myers ER, Lawson HW, McConnell KJ, Kerlikowske K, Melnikow J, Washington AE, Sawaya GF. PMID: 16449119.
-
Discontinuation of postmenopausal hormone therapy. Am J Med. 2005 Dec 19; 118 Suppl 12B:163-5. Grady D, Sawaya GF. PMID: 16414343.
-
A 21-year-old woman with atypical squamous cells of undetermined significance. JAMA. 2005 Nov 02; 294(17):2210-8. Sawaya GF. PMID: 16264163.
-
Cervical cancer screening continues to limit provision of contraception. Contraception. 2005 Sep; 72(3):179-81. Schwarz EB, Saint M, Gildengorin G, Weitz TA, Stewart FH, Sawaya GF. PMID: 16102551.
-
Current cervical neoplasia screening practices of obstetrician/gynecologists in the US. Am J Obstet Gynecol. 2005 Feb; 192(2):414-21. Saint M, Gildengorin G, Sawaya GF. PMID: 15695980.
-
Papanicolaou testing: when does more become less? Am J Med. 2005 Feb; 118(2):159-60. Sawaya GF. PMID: 15694901.
-
Cervical cancer screening among women without a cervix. JAMA. 2004 Oct 06; 292(13):1551; author reply 1551-2. Saraiya M, Sawaya GF. PMID: 15467052.
-
Should routine screening Papanicolaou smears be done for women older than 65 years? Arch Intern Med. 2004 Feb 09; 164(3):243-5; discussion 247-8. Sawaya GF. PMID: 14769617.
-
Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med. 2003 Oct 16; 349(16):1501-9. Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE. PMID: 14561792.
-
Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol. 2003 Oct; 102(4):765-73. Chan PG, Sung HY, Sawaya GF. PMID: 14551007.
-
Testing for human papillomavirus in women with abnormal pap smear results. JAMA. 2002 Sep 18; 288(11):1350-1; author reply 1351-2. Sawaya GF, Smith-McCune K. PMID: 12234220.
-
Clinical practice. Current approaches to cervical-cancer screening. N Engl J Med. 2001 May 24; 344(21):1603-7. Sawaya GF, Brown AD, Washington AE, Garber AM. PMID: 11372013.
-
Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA. 2001 May 02; 285(17):2232-9. Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. PMID: 11325325.
-
Cervical neoplasia risk in women provided hormonal contraception without a Pap smear. Contraception. 2001 Feb; 63(2):57-60. Sawaya GF, Harper C, Balistreri E, Boggess J, Darney P. PMID: 11292467.
-
The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS). Ann Intern Med. 2000 Dec 19; 133(12):942-50. Sawaya GF, Grady D, Kerlikowske K, Valleur JL, Barnabei VM, Bass K, Snyder TE, Pickar JH, Agarwal SK, Mandelblatt J. PMID: 11119395.
-
Hysterectomy and urinary incontinence: a systematic review. Lancet. 2000 Aug 12; 356(9229):535-9. Brown JS, Sawaya G, Thom DH, Grady D. PMID: 10950229.
-
Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol. 2000 Aug; 96(2):219-23. Sawaya GF, Kerlikowske K, Lee NC, Gildengorin G, Washington AE. PMID: 10908766.
-
Cervical cancer screening: which techniques should be used and why? Clin Obstet Gynecol. 1999 Dec; 42(4):922-38. Sawaya GF, Washington AE. PMID: 10572705.
-
New technologies in cervical cytology screening: a word of caution. Obstet Gynecol. 1999 Aug; 94(2):307-10. Sawaya GF, Grimes DA. PMID: 10432148.
-
Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism. Am J Med. 1998 Jul; 105(1):41-3. Grady D, Sawaya G. PMID: 9688020.
-
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 1998 Mar 04; 279(9):688-95. Yaffe K, Sawaya G, Lieberburg I, Grady D. PMID: 9496988.
-
Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol. 1996 May; 87(5 Pt 2):884-90. Sawaya GF, Grady D, Kerlikowske K, Grimes DA. PMID: 8677129.
-
Hepatotoxicity with the administration of nifedipine for treatment of preterm labor. Am J Obstet Gynecol. 1992 Aug; 167(2):512-3. Sawaya GF, Robertson PA. PMID: 1497061.
US